Central muscarinic effects of physostigm
β
David S. Janowsky; S. Craig Risch; Brian Kennedy; Michael Ziegler; Leighton Huey
π
Article
π
1986
π
Springer
π
English
β 507 KB
The mechanism by which physostigmine exerts its behavioral, neuroendocrine and cardiovascular effects was explored in two separate experiments. In the first, the centrally-acting cholinesterase inhibitor physostigmine was compared with the non-centrally-acting agent neostigmine. In contrast to physo